|
Welcure Drugs & Pharmaceuticals Ltd.
|
Ratio Analysis
|
|
|
You can view the
Ratio Analysis
for the last 5 years.
|
Market Cap. (Rs.)
|
109.32 Cr.
|
P/BV
|
1.07
|
Book Value (Rs.)
|
9.12
|
|
52 Week High/Low (Rs.)
|
16/6
|
FV/ML
|
10/1
|
P/E(X)
|
50.41
|
|
Bookclosure
|
30/09/2024
|
EPS (Rs.)
|
0.19
|
Div Yield (%)
|
0.00
|
|
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | PR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| PER SHARE RATIOS | | | | | |
| | | | | | |
| Basic EPS (Rs.) | 0.36 | -0.12 | 0.08 | 0.02 | 0.05 |
| Diluted EPS (Rs.) | 0.36 | -0.12 | 0.08 | 0.02 | 0.05 |
| Cash EPS (Rs.) | 0.19 | -0.10 | 0.07 | 0.01 | 0.04 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 9.12 | 0.99 | 1.13 | 0.07 | 0.05 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 9.12 | 0.99 | 1.13 | 0.07 | 0.05 |
| Revenue From Operations / Share (Rs.) | 2.18 | 0.00 | 0.00 | 0.08 | 0.10 |
| PBDIT / Share (Rs.) | 0.24 | -0.10 | 0.07 | 0.01 | 0.04 |
| PBIT / Share (Rs.) | 0.24 | -0.12 | 0.07 | 0.01 | 0.04 |
| PBT / Share (Rs.) | 0.24 | -0.12 | 0.07 | 0.01 | 0.04 |
| Net Profit / Share (Rs.) | 0.19 | -0.12 | 0.07 | 0.01 | 0.04 |
| | | | | | |
| PROFITABILITY RATIOS | | | | | |
| | | | | | |
| PBDIT Margin (%) | 11.35 | 0.00 | 0.00 | 22.45 | 41.33 |
| PBIT Margin (%) | 11.32 | 0.00 | 0.00 | 22.45 | 41.33 |
| PBT Margin (%) | 11.32 | 0.00 | 0.00 | 22.45 | 41.33 |
| Net Profit Margin (%) | 8.83 | 0.00 | 0.00 | 22.45 | 41.33 |
| Return on Networth / Equity (%) | 2.11 | -12.97 | 6.71 | 25.35 | 79.39 |
| Return on Capital Employeed (%) | 1.23 | -12.97 | 6.71 | 25.35 | 79.39 |
| Return On Assets (%) | 0.81 | -12.69 | 6.65 | 24.35 | 75.47 |
| Long Term Debt / Equity (X) | 1.20 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Debt / Equity (X) | 1.20 | 0.00 | 0.00 | 0.00 | 0.00 |
| Asset Turnover Ratio (%) | 0.18 | 0.00 | 0.00 | 1.24 | 2.73 |
| | | | | | |
| LIQUIDITY RATIOS | | | | | |
| | | | | | |
| Current Ratio (X) | 4.41 | 1.13 | 0.43 | 17.30 | 20.28 |
| Quick Ratio (X) | 0.93 | 1.13 | 0.43 | 17.30 | 20.28 |
| | | | | | |
| VALUATION RATIOS | | | | | |
| | | | | | |
| Enterprise Value (Cr.) | 225.28 | 5.03 | 5.40 | 11.77 | 2.23 |
| EV / Net Operating Revenue (X) | 9.18 | 0.00 | 0.00 | 112.13 | 16.74 |
| EV / EBITDA (X) | 80.81 | -36.18 | 51.47 | 499.33 | 40.49 |
| MarketCap / Net Operating Revenue (X) | 4.16 | 0.00 | 0.00 | 112.76 | 17.09 |
| Price / BV (X) | 0.99 | 3.77 | 3.57 | 128.55 | 32.98 |
| Price / Net Operating Revenue (X) | 4.16 | 0.00 | 0.00 | 113.60 | 17.25 |
| EarningsYield | 0.02 | -0.03 | 0.01 | 0.00 | 0.02 |
